Company Overview and News

EQT Midstream to Expand Mountain Valley Pipeline to South

2018-04-16 zacks
EQT Midstream Partners, LP (EQM - Free Report) has recently revealed its intention to build a natural gas pipeline to connect Virginia and North Carolina. The interstate MVP Southgate pipeline project is backed by shipping commitment from SCANA Corporation's (SCG - Free Report) subsidiary PSNC Energy.

Big League Move For Energy, Midstream Follows

2018-04-15 seekingalpha
Midstream had a solid week, pulled higher by rallies in energy stocks and oil prices. Tuesday was the best day for MLPs all year (+3%) and Wednesday saw follow through, but the other 3 days were negative. Midstream performance was torn between improving sentiment for energy stocks and negative price action among income-oriented stocks like utilities and REITs, which under-performed on higher interest rates.

EQM / EQT Midstream Partners LP / TORTOISE CAPITAL ADVISORS, L.L.C. - NONE (Passive Investment)


EQT Midstream at 4-Year Lows: How Much Upside Does It Offer?

EQT Midstream Partners (EQM), a midstream MLP mainly involved in natural gas gathering, compression, and transportation, is currently trading close to its four-year lows. It has fallen 19.9% since the start of 2018.

'Safer' Dividend Energy Equities Trail Shell Midstream's March Target Gains

2018-04-02 seekingalpha
Broker top-ten net-gain "Safer" dividend energy March stocks (per 1yr. targets) were HEP, DCP, EP, EQGP, GLOP, GPP, VLP, EQM, TEGP, & led by SHLX with 21.6%-55.45% gains.

EQM / EQT Midstream Partners LP null

begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A

24 'Safer' Dividends Out Of My Readers 49 Most Mentioned Dividend Stocks For March

2018-03-25 seekingalpha
From 2/1-3/5/18, Fredrik Arnold dividend "followers" discussed 49 equities and funds in their messages and comments. Some comments were bad news, so bad rogues mixed into a FollowerFavorite/Rogue (FoFa/Ro) list.

My Readers' 49 Most Mentioned Dividend Stocks For March

2018-03-25 seekingalpha
January 30 - March 15, Fredrik Arnold "followers" mentioned 46 equities and 3 funds in comments and suggestions. Some lamented bad news so bad news stocks mixed in with favorites.

Reading the Key Steps Leading to EQT’s Midstream Separation

EQT Corporation (EQT) expects the midstream separation to complete by the end of 3Q18. The midstream spin-off is subject to customary conditions.

EQT: S&P 500’s Top Loser on March 15

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Who’s Protected from FERC’s Revised Income Tax Policy?

Midstream companies such as Kinder Morgan (KMI), Targa Resource (TRGP), and ONEOK (OKE) are taxed as C-corps, so the revised policy doesn’t apply to them. C-corps reacted negatively to the news, but they recovered by the end of the trading session. Williams Companies (WMB) and Enbridge Inc. (ENB), which are also C-corps, were an exception due to their GP-LP model and dependence on limited partnerships for their distribution income.

Dividend Sensei's Portfolio Update 26: Let The Next Market Crash Make You Rich

2018-03-13 seekingalpha
The bull market just turned nine, but history and positive fundamentals indicate that it might have many more years to run.

Last Week’s Worst MLP Performers

Summit Midstream Partners (SMLP), a midstream MLP mainly involved in natural gas gathering, processing, and compression, was the worst MLP performer last week. It fell 4.5%. The partnership has lost 22.4% since the start of this year. SMLP’s recent weakness could be due to its weak 4Q17 earnings. The partnership posted flat adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $72.

WPZ to Continue Its Focus on Natural Gas Pipeline Expansion in 2018

So far in this series, we’ve looked into the capital spending and distribution growth plans for the top three US Midstream companies—Enterprise Product Partners (EPD), Kinder Morgan (KMI), and Energy Transfer Partners (ETP).

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 26885B100